RETRACTED ARTICLE: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension

Abstract

We, the Editors-in-Chief, authors and Publisher, have retracted the following article:

John McConnell, S. Pinar Bilir, Yifan Xu, Yuen Tsang & Sumeet Panjabi (2023) Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension, Journal of Medical Economics, 26:1, 1349-1355, DOI: 10.1080/13696998.2023.2254160

The article has been retracted due to errors in the analysis which affect the reported results of the paper, findings, and conclusions. Upon realising the error, the authors agreed to have the article retracted. There are no concerns regarding research or publishing conduct and the authors plan to resubmit the paper for consideration by the journal.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

View retraction statement:

Statement of Retraction: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension